Gene · 8650
Papers2,413
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,413
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner. | Sci Rep | 2023 | 38129484 | PubTator, text mining | PubMed |
| Emerging roles of circular RNAs in the invasion and metastasis of head and neck cancer: Possible functions and mechanisms. | Cancer Innov | 2023 | 38125767 | PubTator, text mining | PubMed |
| The benign nature and rare occurrence of cardiac myxoma as a possible consequence of the limited cardiac proliferative/ regenerative potential: a systematic review. | BMC Cancer | 2023 | 38110859 | PubTator, text mining | PubMed |
| A positive feedback loop between ZEB2 and ACSL4 regulates lipid metabolism to promote breast cancer metastasis. | Elife | 2023 | 38078907 | PubTator, text mining | PubMed |
| Effects of mammary cancer and chemotherapy on neuroimmunological markers and memory function in a preclinical mouse model. | Brain Behav Immun Health | 2023 | 38058985 | PubTator, text mining | PubMed |
| Cancer-associated mesenchymal stem/stromal cells: role in progression and potential targets for therapeutic approaches. | Front Immunol | 2023 | 38022534 | PubTator, text mining | PubMed |
| The Notch signaling-regulated angiogenesis in rheumatoid arthritis: pathogenic mechanisms and therapeutic potentials. | Front Immunol | 2023 | 38022508 | PubTator, text mining | PubMed |
| Recent advances in melittin-based nanoparticles for antitumor treatment: from mechanisms to targeted delivery strategies. | J Nanobiotechnology | 2023 | 38017537 | PubTator, text mining | PubMed |
| Role of epithelial-mesenchymal transition factor SNAI1 and its targets in ovarian cancer aggressiveness. | J Cancer Metastasis Treat | 2023 | 38009093 | PubTator, text mining | PubMed |
| UBE2C promotes malignancy of cutaneous squamous cell carcinoma. | Skin Res Technol | 2023 | 38009019 | PubTator, text mining | PubMed |
| Implications of TDP-43 in non-neuronal systems. | Cell Commun Signal | 2023 | 37996849 | PubTator, text mining | PubMed |
| Jagged1 contained in MSC-derived small extracellular vesicles promotes squamous differentiation of cervical cancer by activating NOTCH pathway. | J Cancer Res Clin Oncol | 2023 | 37994984 | PubTator, text mining | PubMed |
| Histone lactylation regulates cancer progression by reshaping the tumor microenvironment. | Front Immunol | 2023 | 37965331 | PubTator, text mining | PubMed |
| Recent progress in discovery of novel AAK1 inhibitors: from pain therapy to potential anti-viral agents. | J Enzyme Inhib Med Chem | 2023 | 37955299 | PubTator, text mining | PubMed |
| Alcohol and Skeletal Muscle in Health and Disease. | Alcohol Res | 2023 | 37937295 | PubTator, text mining | PubMed |
| From Physiology to Pathology: The Role of Mitochondria in Acute Kidney Injuries and Chronic Kidney Diseases. | Kidney Dis (Basel) | 2023 | 37901706 | PubTator, text mining | PubMed |
| The role of alternative pre-mRNA splicing in cancer progression. | Cancer Cell Int | 2023 | 37875914 | PubTator, text mining | PubMed |
| Notch receptor/ligand diversity: contribution to colorectal cancer stem cell heterogeneity. | Front Cell Dev Biol | 2023 | 37860822 | PubTator, text mining | PubMed |
| MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review). | Oncol Rep | 2023 | 37859595 | PubTator, text mining | PubMed |
| SPTAN1/NUMB axis senses cell density to restrain cell growth and oncogenesis through Hippo signaling. | J Clin Invest | 2023 | 37843276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8650/papers?page=7